News | Flat Panel Displays | September 17, 2015

Barco Earns Frost & Sullivan Innovation Leadership Award for Coronis Uniti Display

Flat panel display supports PACS and multimodality breast imaging on a single screen

Barco, Frost & Sullivan, Visionary Innovation Leadership, award, Coronis Uniti, 2015

Coronis Uniti image courtesy of Barco

September 17, 2015 — Healthcare imaging specialist Barco announced it has received the 2015 Frost & Sullivan Award for best practices in Visionary Innovation Leadership in the medical imaging displays market. The award comes on the heels of the release of the Coronis Uniti display system in 2014.

“Coronis Uniti is an evolutionary platform, a universal imaging display system that can support every type of procedure across imaging modalities,” commented David Frigstad, Frost & Sullivan’s chairman. “The product reflects a visionary understanding of the future which is why Frost & Sullivan decided to recognize Barco as the Visionary Innovation Leader in the global medical imaging displays market.” 

Coronis Uniti is the only display that can support picture archiving and communication systems (PACS) as well as multimodality breast imaging — i.e. 3-D mammography, digital mammography, breast magnetic resonance imaging (MRI) and ultrasound — on a single screen. This provides an alternative to multi-monitor workstation configurations and eliminates the need to change workstations to complete patient studies. Its 33-inch screen with 12-megapixel resolution renders high-quality grayscales as well as color and fused modalities, in 2-D and 3-D, static and dynamic. 

“Coronis Uniti has the potential to elevate a healthcare organization’s diagnostic viewing environment and contribute actively to meeting many of the high-level objectives sought by these organizations, such as enabling earlier detection of pathologies, gaining more confidence in final diagnoses and reducing the rate of patient recalls,” Frigstad concluded. 

Frost & Sullivan also applauded Barco for its significant contributions to the educational and lobbying efforts necessary to advance the regulatory environment and the clinical adoption curve. In the case of Coronis Uniti, Barco has been actively participating in industry efforts to establish standards for the use of color in medical imaging and has been taking a leadership role in defining the color standard display function (CDSF).

For more information: www.barco.com

Related Content

brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
Radiation dose tracking in medical imaging is helping increase patient safety by lower X-ray doses.
Feature | Radiation Dose Management | July 26, 2017 | Dave Fornell
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology the past few years and has pr
Sponsored Content | Videos | CT Angiography (CTA) | July 13, 2017
Todd Villines, M.D., FACC, FAHA, FSCCT, director of cardiac CT, Georgetown Medical Center, and president of the Socie
Sponsored Content | Videos | CT Angiography (CTA) | July 10, 2017
David Bluemke, M.D., Ph.D., FAHA, professor of radiology, University of Wisconsin - Madison, incoming editor of RSNA’
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
The Magnetom Vida with BioMatrix technology
News | Magnetic Resonance Imaging (MRI) | June 16, 2017
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Vida 3 Tesla (3T) magnetic resonance imaging (MRI...

Image courtesy of Carestream

News | Business | June 13, 2017
Communication between patients and radiologists is a key element of patient-centered care, a major focus of the...
News | PET-CT | June 12, 2017
Siemens Healthineers has announced that the Food and Drug Administration (FDA) has cleared Biograph Horizon Flow...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
Toshiba Medical launches its new Celesteion PUREViSION Edition PET/CT system to help diagnose and treat oncology patients

Toshiba Medical launches its new Celesteion PUREViSION Edition PET/CT system to help diagnose and treat oncology patients.

News | PET-CT | June 09, 2017
Oncologists have access to advanced imaging technologies for excellent cancer patient care with the new Celesteion...
Overlay Init